EUVIMEDEUVIMED entdecken
Crossref

Metformin Accelerates Wound Healing in Wistar Albino Rats: Evidence from an Excision Wound Model

Sachin G. Jagdale, Ramchandra P. Limaye, Ravindra P. Kulkarni

International Journal of Drug Delivery Technology · 16.04.2026 · 16 (13s)

DOI: 10.25258/ijddt.16.13s.59 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 16.04.2026. Verfasst von Sachin G. Jagdale und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Wound healing is a complicated physiological procedure that incorporates inflammation, proliferation and remodelling of tissue. Metabolic disorders and vascular dysfunction are usually linked to impaired wound healing. Metformin is a commonly used biguanide used in the management of type 2 diabetes mellitus, which has been described to have a number of pleiotropic effects other than the glycemic control such as the ability to enhance endothelial function and the angiogenesis process.

Objective

The present study was aimed to evaluate the wound healing activity of metformin in Wistar albino rats using an excision wound model.

Methods

Twenty-four (180 +- 20 g) Wistar albino rats were randomly split into four groups (n = 6). Group I was the control which was given normal saline, and Groups II, III and IV were given metformin 30 mg/kg, 60 mg/kg and 90mg/kg, respectively. Each rat had an incision wound on the back that was about 500 mm2 in diameter and was made through the Morton and Malone method. On days 7, 14 and 21 post wounding, wound contraction was recorded. The time of the epithelization was noted as well. Data were expressed as mean ± SEM and analyzed using one-way ANOVA.

Results

Metformin treatment significantly enhanced wound contraction compared with the control group (p < 0.05) and reduced epithelization period. On day 7, wound closure percentages were 32.87 ± 10.42 in the control group and 79.52 ± 11.92, 81.42 ± 9.41, and 93.94 ± 3.72 in the metformin-treated groups (30, 60, and 90 mg/kg respectively). By day 14, wound closure increased to 93.36 ± 2.20, 95.80 ± 2.31, and 98.60 ± 0.47 in the treatment groups. The epithelization period was significantly reduced in metformin-treated animals (11–12.8 days) compared with control animals (20 days).

Conclusion

Metformin significantly accelerates wound healing by enhancing wound contraction and reducing the epithelization period in rats. These findings suggest that metformin may promote tissue repair through mechanisms involving improved endothelial function, enhanced angiogenesis, and activation of AMPK-mediated signaling pathways.

Zitieren

APA

Jagdale, S. G., Limaye, R. P., & Kulkarni, R. P. (2026). Metformin Accelerates Wound Healing in Wistar Albino Rats: Evidence from an Excision Wound Model. International Journal of Drug Delivery Technology, 16(13s). https://doi.org/10.25258/ijddt.16.13s.59

Vancouver

Jagdale SG, Limaye RP, Kulkarni RP. Metformin Accelerates Wound Healing in Wistar Albino Rats: Evidence from an Excision Wound Model. International Journal of Drug Delivery Technology. 2026;16(13s). doi:10.25258/ijddt.16.13s.59

BibTeX
@article{Jagdale2026,
  author = {Jagdale, Sachin G. and Limaye, Ramchandra P. and Kulkarni, Ravindra P.},
  title = {Metformin Accelerates Wound Healing in Wistar Albino Rats: Evidence from an Excision Wound Model},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {13s},
  doi = {10.25258/ijddt.16.13s.59}
}
Kostenlos starten →